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Hydrogen gas distribution in 
organs after inhalation: Real-time 
monitoring of tissue hydrogen 
concentration in rat
Ryo Yamamoto1, Koichiro Homma1, sayuri suzuki1, Motoaki sano2 & Junichi sasaki1
Hydrogen has therapeutic and preventive effects against various diseases. Although animal and clinical 
studies have reported promising results, hydrogen distribution in organs after administration remains 
unclear. Herein, the sequential changes in hydrogen concentration in tissues over time were monitored 
using a highly sensitive glass microsensor and continuous inhalation of 3% hydrogen gas. The hydrogen 
concentration was measured in the brain, liver, kidney, mesentery fat and thigh muscle of rats. The 
maximum concentration, time to saturation, and other measurements representing the dynamics of 
distribution were obtained from the concentration curves, and the results obtained for different organs 
were compared. The time to saturation was significantly longer (20.2 vs 6.3–9.4 min. P = 0.004 in all 
cases) and increased more gradually in muscle than in the other organs. The maximum concentration 
was the highest in liver and the lowest in the kidney (29.0 ± 2.6 vs 18.0 ± 2.2 μmol/L; P = 0.03 in all 
cases). The concentration varied significantly depending on the organ (P = 0.03). These results provide 
the fundamentals for elucidating the mechanisms underlying the in vivo favourable effects of hydrogen 
gas in mammalian systems.
Hydrogen gas (molecular hydrogen) has emerged as an attractive medicinal agent due to its therapeutic and 
preventive effects in various diseases1–7. Several studies on animals have shown that the hydrogen reduces the 
reactive oxygen species (ROS) in tissues1,4–6,8 and has other antioxidant and/or anti-inflammatory effects on 
ischaemia-reperfusion injury in which the ROS are produced in excess4,9,10. Some clinical investigations have 
also shown the beneficial effects of inhaled hydrogen gas on acute myocardial infarction and out-of-hospital 
cardiac arrest4,11. Furthermore, studies regarding the safety and feasibility of hydrogen gas have reported that the 
hydrogen gas can be supplied to patients with a simple device that can be adapted to various clinical settings11,12.
Although hydrogen gas is produced by intestinal microbiota via fermentation of sugars and a considerable 
amount can be detected in breath13, the physiological mechanism by which the artificial administration of hydro-
gen provides favourable therapeutic effects remains unclear14. While recent studies have reported that the hydro-
gen gas affects cell signal transduction and may prevent cellular apoptosis15,16, another work reported that the 
oxidation-reduction reactions involving molecular hydrogen only occur with strong ROS, which cause tissue 
injury and not with weak, beneficial ROS14.
Despite such promising data and increasing popularity, studies investigating the hydrogen gas distribution 
or dynamics in organs after administration are generally lacking. Since hydrogen gas has low molecular weight 
and can rapidly diffuse through cell membranes1,17, it is believed that the concentration of hydrogen in the body 
would reach saturation shortly (minutes) after administration9. However, one study estimating the hydrogen con-
centrations in homogenised rat tissues revealed different peak concentrations among organs following one-time 
inhalation or intraperitoneal administration of hydrogen18. The same study also proposed variable dynamics of 
hydrogen concentration in organs over time18. In addition, there is a considerable debate on the administration 
method(s) that would provide hydrogen efficiently to the target organs19.
In an effort to clarify the hydrogen tissue distribution and dynamics after supply, the present study examines 
the sequential changes of hydrogen concentration in rat organs and tissues over time with continuous initiation 
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of 3% hydrogen gas. The hydrogen concentration was measured in several organs by real-time monitoring with a 
highly sensitive glass microsensor, which is a practical method to measure hydrogen concentration in vivo.
Results
Definition of hydrogen concentration measurements. The values of concentration provided by the 
real-time monitoring were fit to a first-order lag curve. Then, some substantial measurements from concentra-
tion curves were selected based on the basics of physics (Fig. 1) and compared to elucidate the differences in 
hydrogen distribution in organs. Cmax (i.e., saturation) was defined as the concentration on the highest plateau 
where changes in hydrogen concentration were less than 1% of the difference between baseline and maximum 
concentrations over 1 min. Cmax was then adjusted using the microsensor signals obtained before hydrogen gas 
inhalation and used as an in vivo calibration (Cmax-adjusted). Tsat was defined as the time between the initiation of gas 
inhalation and beginning of the Cmax plateau (saturation) while T10, T63, and T90 represent the time taken to reach 
10, 63, and 90% of the Cmax-adjusted value, respectively. T63 represents the time constant, a parameter that reliably 
characterises the speed of changes in time-invariant curves. Tzero was the duration of the initial (lowest) plateau, 
defined as the time needed for the hydrogen concentration to reach 3% of the Cmax-adjusted value. Tzero was then 
adjusted to fit the concentration curves to a first-order lag model.
Maximum Concentration (Cmax) for hydrogen. Cmax values for each organ are shown in Fig. 2. The 
highest mean Cmax was found in the liver (29.0 ± 2.6 μmol/L) and the lowest in the kidney (18.0 ± 2.2 μmol/L). 
Figure 1. Definition of hydrogen concentration curve measurements. Important concentration curve 
measurements were as follows. Cmax - the maximum plateau concentration where the concentration changes 
were less than 1% of the difference between baseline and maximum concentrations (i.e., saturation) over 1 min. 
Cmax-adjusted - Cmax values adjusted by microsensor signals obtained before staring the inhalation and used as an 
in vivo calibration. Tsat - the time between initiation of inhalation and beginning of saturation. T10, T63, and T90 
- the time taken to reach 10, 63, and 90% of Cmax-adjusted, respectively. Tzero - the time required for the hydrogen 
concentration to reach 3% of Cmax-adjusted.
Figure 2. Maximum hydrogen concentration (Cmax). The liver had the highest mean Cmax while the kidney had 
the lowest. Although the Cmax varied significantly depending on the organ (P = 0.02 by analysis of variance), 
the inter-organ comparisons only revealed significant differences between the liver and kidney (*P < 0.05 by 
unpaired t-test) and liver and muscle (*P < 0.05 by unpaired t-test). Cmax-adjusted was also the highest in the liver 
and the lowest in the kidney. Cmax-adjusted was significantly different between the liver and kidney (**P = 0.04 by 
unpaired t-test).
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Although the Cmax varied significantly depending on the organ (P = 0.02 by analysis of variance), the inter-organ 
comparisons only revealed significant differences between the liver and kidney (P = 0.03) and liver and muscle 
(18.4 ± 1.7 μmol/L in the muscle, P = 0.04). The distribution of Cmax among the target organs remained the same 
after in vivo calibration (Cmax-adjusted). The Cmax-adjusted value was also the highest in the liver (27.1 ± 1.8 μmol/L) and 
the lowest in the kidney (17.9 ± 1.9 μmol/L). The Cmax-adjusted was significantly different between liver and kidney 
(P = 0.04).
Hydrogen distribution and saturation dynamics. The dynamic of hydrogen concentration changes 
before reaching saturation regardless the organ, as illustrated in Fig. 3. Measurements of saturation dynamics (Tsat, 
T90, T63, T10, and Tzero) are shown in Fig. 4. The Tsat was significantly longer and increased more gradually in mus-
cle compared to the other examined organs (20.1 vs 6.3, 7.8, 8.2 and 9.4 min in brain, liver, kidney and mesentery 
fat, respectively (P = 0.004 in all cases), as shown in Fig. 4). Similar results were found at T10 (1.7 vs 0.5–0.9 min, 
P = 0.04 in all cases), T63 (7.4 vs 1.9–3.2 min, P = 0.01 in all cases), and T90 (14.4 vs 3.6–5.7 min, P = 0.01 in all 
cases) (Fig. 4). Changes in hydrogen concentration were similar among the brain, liver, kidney and mesentery fat, 
with no significant differences at T10, T63, T90 and Tsat between these organs.
The Tzero was comparable between muscle and the other organs (1.0 vs 0.4–0.6 min, P = 0.06 in all cases, Fig. 4). 
Similar results were found for the adjusted Tzero (1.2 min for muscle vs 0.4–0.8 min for other organs, P = 0.12 in 
all cases, Supplementary Table S1).
Hydrogen desaturation dynamics. After hydrogen was inhaled, the hydrogen concentration in each 
organ returned to baseline (Supplementary Fig. S1). The hydrogen concentration decreased slower in muscle 
Figure 3. Hydrogen distribution curve until saturation. The hydrogen concentration increased more gradually 
in thigh muscle compared to the other organs. The liver had the highest Cmax while the kidney had the lowest. 
Liver, n = 6, brain, n = 8, mesentery fat, n = 4, kidney, n = 5, thigh muscle, n = 5.
Figure 4. Hydrogen saturation dynamics. Time to saturation (Tsat) and the time taken to reach 10% (T10), 63% 
(T63), and 90% (T90) of adjusted Cmax-adjusted were all significantly longer in the thigh muscle than in the other 
organs (Tsat, **P = 0.004 by Kruskal–Wallis test, T10, T63, and T90, *P < 0.05 by Kruskal–Wallis test). The T10, T63, 
T90 and Tsat were not significantly different between brain, liver, kidney and mesentery fat. The duration of the 
initial plateau (Tzero) was comparable for all organs.
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than in the other target organs while changes in concentration decreased with almost the same rate in brain, liver, 
kidney and mesentery fat.
Discussion
In the present study, the distribution and real-time changes in hydrogen concentration in several rat organs (i.e., 
muscle, brain, kidney, liver, and mesentery fat) were monitored by continuous inhalation of 3% hydrogen gas. 
Generally, the results revealed that saturation distribution and dynamics were significantly different among the 
different target organs. Notably, the time needed to saturate tissues with artificially administered hydrogen and 
Cmax values did not correlate with each other. To the best of our knowledge, this is the first study reporting on 
differences of hydrogen concentration distribution in animal tissues obtained by comparing the concentration 
curves.
Since molecular hydrogen can penetrate cell membranes due to its electrical neutrality and low molecular 
weight, many studies have suggested that the hydrogen gas can diffuse by organs immediately after supply6–10,14,17. 
A previous study conducted on rats reported that the hydrogen concentration in various organs reached the max-
imum levels 5 min after oral or intraperitoneal administration of a hydrogen super-rich saline solution and 1 min 
after intravenous injection18. Another study also showed that the hydrogen concentration in arterial blood and 
myocardium of rats similarly reached the maximum 5 min after gas inhalation9.
In contrast, more delayed hydrogen saturation was reported in the thigh muscle of rats9, suggesting that the 
distribution of hydrogen is not completely dependent on gaseous diffusion. In the current study it was found 
that Tsat, T90, T63, and T10 all were significantly longer in muscle than in the brain, liver, kidney and mesentery fat. 
These results would be mainly explained by the fact that the blood flow in the muscle of rats is lower than that 
in other organs, particularly under anaesthesia20. Considering inhaled hydrogen would initially dissolve into the 
blood within the lungs, it could be distributed throughout the body by regional blood flow in addition to gaseous 
diffusion. Moreover, a study on the ischaemic myocardium of rats reported an increase in hydrogen concentration 
immediately after restoration of coronary artery blood flow9.
Despite the delayed saturation of hydrogen in the thigh muscle, the Tzero was comparable among target organs 
examined in the present study, even after its adjustment. This supports the speculation that the hydrogen would 
be supplied in large part through the blood, because the arterial blood reaches organs simultaneously regardless 
of flow rate. It should also be emphasized that if the hydrogen is distributed only by gaseous diffusion, changes 
in hydrogen concentration would depend on the distance between the face (gas supply hood was attached) and 
each organ, and the hydrogen would rapidly diffuse (low Tzero) to the brain, because it is closer to the face than the 
thigh muscle (high Tzero) [known as Fick’s laws]20.
Theoretical models of hydrogen distribution were descripted in Fig. 5. In gaseous diffusion model, hydrogen 
concentration would increase more rapidly and would saturate at higher value in the brain than the muscle and 
other organs based on the distance between the gas supply hood (the face and head) and each organ, although 
maximum concentration would be lower than the administered level (22.1 μmol/L) due to high diffusion coeffi-
cient of hydrogen gas (Fig. 5A). In blood flow model, hydrogen concentration would increase more gradually in 
the muscle than other organs due to lower blood flow of muscle, while maximum concentrations would be similar 
across organs because arterial blood would be saturated at the administered level (Fig. 5B). Comparing these the-
oretical models with the results of current study (Fig. 3), we believe that the hydrogen would be supplied mostly 
through the blood in addition to gaseous diffusion.
Although the molecular/cellular physiology underlying the differences in saturated hydrogen concentration 
by organs remains unclear, it has been suggested that the hydrogen accumulates in polysaccharide, such as glyco-
gen, or in the lipid phase of cells21,22. The highest concentration of hydrogen in the liver observed in the present 
study (29.0 ± 2.6 μmol/L) was higher than the administered level (22.1 μmol/L), indicating hydrogen storage in 
the liver.
Figure 5. Theoretical models of hydrogen distribution. (A) In gaseous diffusion model, hydrogen 
concentration would increase more rapidly and would saturate at higher value in the brain than the muscle and 
other organs based on the distance between the gas supply hood (the face and head) and each organ, although 
maximum concentration would be lower than the administered level (22.1 μmol/L) due to high diffusion 
coefficient of hydrogen gas. (B) In blood flow model, hydrogen concentration would increase more gradually 
in the muscle than other organs due to lower blood flow of muscle, while maximum concentrations would be 
similar across organs because arterial blood would be saturated at the administered level.
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Contradictory results have been reported regarding the Cmax of hydrogen. While a recent study showed that 
the muscle accommodated the highest concentration of hydrogen via inhalation18, another study reported lower 
concentration in the muscle than in myocardium9. High concentrations were also shown in the spleen and pan-
creas after oral or intraperitoneal administration of hydrogen18. On the other hand, the present study shows that 
the liver has the highest Cmax, whereas it considerably varies between organs.
These discrepancies are likely related to the experimental methods for measurement. For example, Cmax can 
only be determined by continuous monitoring, since it is not known when the hydrogen concentration will reach 
a maximum in a certain organ/tissue. It is also important to underline that the hydrogen rapidly diffuses and can 
penetrate even glass containers23, therefore, it should be administered continuously and its concentration should 
be measured in vivo, not via sampled tissues, to obtain accurate saturation measurements9. Moreover, the admin-
istration methods should be also considered, since the hydrogen can be introduced and distributed through-
out the body by both gaseous diffusion and blood flow. Accordingly, we believe that maximum concentrations 
obtained in the current study on continuously inhaled model are more accurate than ones in the previous studies.
The results of this study must be interpreted in the context of the study design. We only administer the 3% 
hydrogen with gas inhalation and its distribution to the body might differ when administered by other methods/
routes or other concentrations. However, inhalation allows the application of a constant dose and by which Cmax 
can be obtained appropriately. Furthermore, it was shown that the inhalation of less than 4% hydrogen is practical 
and safe for patients14. A double-blind, randomised control trials using 2% hydrogen inhalation are ongoing11,24. 
Therefore, we believe that the current results may be applicable to clinical settings.
Another limitation to our study is related to the lack of measurement of hydrogen concentration in the arterial 
blood, which may affect the hypotheses regarding the hydrogen distribution through the blood flow in conjunc-
tion with gaseous diffusion. Although the hydrogen in the blood has been reported in past studies9,18, it is techni-
cally difficult to monitor the real-time concentration as the insertion of the microsensor into major vessels causes 
bleeding. Loss of blood volume would significantly impair regional blood flow in organs and tissues, which could 
alter results considerably.
Furthermore, although negative value in hydrogen concentration is not physically correct, some negative 
concentrations were detected. We believe the electric signal produced by hydrogen microsensor might have been 
affected by temperature, salinity, or oscillation of tissue, which are known to influence electric current signals 
generated at anode of microsensor. However, since we performed calibration to minimize measurement error and 
the negative values were small and recorded only in the brain, our results would still provide the speculation that 
the hydrogen would be supplied mostly through the blood.
In conclusion, the present study reported on hydrogen concentrations and significantly various distributions 
among organs in rats exposed to continuous hydrogen gas inhalation. While thigh muscle required a longer time 
to saturate, the liver had the highest Cmax with considerable variation between organs. These results are essential to 
elucidate the mechanisms underlying the beneficial therapeutic effects of hydrogen in mammalian systems, and 
future investigations using the inhalation of hydrogen gas should consider the significant differences in hydrogen 
distribution between organs when designing experiments and interpreting results.
Methods
Animals. The protocol used in the present study was approved by the Research Council and Animal Care and 
Use Committee of the Research Institute of Keio University (Tokyo, Japan) and performed in accordance with 
the guidelines for the care and use of laboratory animals established by the Japanese Pharmacological Society and 
the National Institutes of Health. Eight-week old male Sprague-Dawley rats (250–270 g) were purchased from 
Sankyo Labo Service Corporation, Inc. (Tokyo, Japan) and maintained in a temperature- and light-controlled 
room (20 °C, 12-h light/12-h dark cycle). The rats had free access to food and water before the experiment.
Hydrogen gas preparation. Hydrogen gas (3%) was prepared using a hydrogen gas supply device (Nihon 
Kohden Co., Tokyo, Japan) and administered to rats with a rate of 0.2 L/min. Hydrogen gas stored in the device 
was mixed with air, then the targeted concentration was measured inside the supply device. The gas flow rate was 
adjusted at the output port of the device and validated with a flow metre attached to the respiratory circuit.
Hydrogen concentration monitoring. A highly sensitive hydrogen microsensor (Unisense, Aarhus, 
Denmark) composed of a silicone membrane, hydrogen oxidising platinum anode, and a glass tip (diameter, 500 
μm) was used to measure the hydrogen concentration in real-time. The silicone membrane at the glass tip is used 
for separating hydrogen from gas mixtures in tissue. The hydrogen selectively diffuses through the membrane to 
the hydrogen oxidizing platinum anode and the microsensor produces an electric current (signal). The electrical 
signal was amplified with the device’s multi meter and translated into hydrogen concentration units. Since the 
signal is slightly affected by temperature, salinity, or oscillation of tissue, calibration was performed using distilled 
water warmed to 37 °C and 3% hydrogen solution (22.1 μmol/L in water).
Experimental protocol. Rats were anaesthetised intraperitoneally with a combination of 0.3 mg/kg medeto-
midine, 2.0 mg/kg midazolam, and 2.5 mg/kg butorphanol. They were appropriately anesthetized for the entire 
hydrogen administration procedure and until concentration levels returned to baseline. The respiratory circuit 
was connected to the gas supply hood, which covered the face and head of rats. Only one of the target organs was 
exposed at a time by minimal incision before inserting the microsensor tip to a depth of about 1 mm below the 
surface of the organ. The sensor body was held by a test tube holder.
To determine baseline levels, the real-time monitoring of hydrogen concentration in the target organ started 
before the administration of hydrogen gas, and the concentration values were recorded every 0.5 s. Inhalation of 
3% hydrogen gas continued until the target tissue became saturated. At this point, the hydrogen administration 
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was discontinued, but the target organ was monitored until the hydrogen concentration returned to baseline. 
Target organs included the right cerebrum, median lobe of the liver, right kidney, fat tissue of the mesentery, 
and muscle of the left thigh (n = 4–8 per organ). The hydrogen gas microsensor was calibrated after each 
measurement.
Statistical analysis. Descriptive statistics are presented as the mean ± standard deviation or as a percent-
age. Inter-organ comparisons of the concentration curves were performed using analysis of variance and/or 
Kruskal–Wallis, unpaired t-, Mann–Whitney U-, Chi-square or Fisher’s exact tests when appropriate. A two-sided 
α threshold of 0.05 was considered statistically significant for all hypotheses tested. All statistical analyses were 
conducted using SPSS ver.24 software (SPSS, Chicago, IL, USA) and Microsoft Excel (Microsoft, Redmond, WA, 
USA).
Data Availability
All data generated or analysed during this study are included in this published article and its Supplementary 
Information files.
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